Head-to-head · WeighScore
He & She MD vs VitaFusions IV
The verdict
He & She MD takes it — 71.5/100 to 62.3/100.
He & She MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. He & She MD is a nationwide telehealth weight-loss clinic offering doctor-prescribed GLP-1 medications: compounded semaglutide and tirzepatide (injectable or oral) plus a microdose option, with brand-name…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | He & She MD | VitaFusions IV |
|---|---|---|
| WeighScore | 71.5/100 | 62.3/100 |
| Grade | C | C |
| Scorecard rank | #91 | #274 |
| Semaglutide | $139/mo (starting dose, promotional rate, compounded) | $149/mo (all doses, plus a separate fee, compounded) |
| Tirzepatide | $199/mo (starting dose, compounded) | $189/mo (all doses, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #91 · C
Strengths
- Transparent intro pricing: injectable GLP-1 from $139/month, oral from $199, microdose from $99
- Compounded semaglutide and tirzepatide (injectable or oral) plus brand access to Ozempic, Wegovy, Zepbound
- Only charged if medication is prescribed; no hidden fees
- Free expedited shipping and unlimited board-certified clinician access
- GLP-1 coaching, nutrition guidance, and in-app progress tracking
Where it loses points
- Compounded GLP-1s are not FDA-approved finished products (per the site FDA disclaimer)
- Does not ship to Louisiana or to PO boxes
- Introductory pricing rises after the 6-month (or 3-month microdose) plan
- Cash-pay model — insurance billing not indicated
Graded #274 · C
Strengths
- Semaglutide confirmed from page metadata
- Published flat package pricing: semaglutide from $149, tirzepatide $189 for a 7-week supply, no insurance/memberships/contracts
Where it loses points
- Advertised prices are 7-week package prices, not monthly; homepage banner ('$199 for 7 weeks') conflicts with the program page ('Starting $149')
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.